What is the growth rate for the Point of Care Diagnostics Market over the forecast period?

The global Point of Care Diagnostics Market is one of the lucrative growth markets, poised to register a 10.2% growth (CAGR) between 2024 and 2032.... Read more

What are the major drivers for Point of Care Diagnostic Market growth?

Some of the key drivers are Increasing Prevalence of infectious diseases, R&D investments in new product launches with a focus on tests with multiplexing features, Rapid growth in remote patient monitoring and telemedicine industries. and more..... Read more

Which Point of Care Diagnostics Market Segments Offer the Most Lucrative Opportunities in the Industry?

Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects..... Read more

What is the period of study of the Point of Care Diagnostics Market?

Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume... Read more

Point of Care Diagnostics Market Size, Share, Trends, Growth Outlook

Point of Care Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), Countries and Companies Report

Home
Healthcare
Point of Care Diagnostic Market
|Published Month : February, 2024
|No. of Pages : 198

Overview
Table of Contents
Segmentation
Sample Request

Point of Care Diagnostics Market is estimated to increase at a growth rate of 10.2% CAGR over the forecast period from 2024 to 2032.

The Point of Care Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory).

An Introduction to Point of Care Diagnostics Market in 2024

Point of Care Diagnostics Market: In 2024, the Point of Care Diagnostics Market continues to witness robust growth driven by the increasing demand for rapid and decentralized testing solutions across various healthcare settings. Point-of-care (POC) diagnostics offer several advantages, including rapid turnaround time, ease of use, and accessibility, making them invaluable tools for timely clinical decision-making, patient management, and disease surveillance. The market is characterized by the development of innovative POC testing platforms, such as handheld devices, portable analyzers, and smartphone-based applications, enabling real-time and on-site detection of various analytes, including infectious agents, biomarkers, and metabolic parameters. Additionally, the growing prevalence of infectious diseases, rising healthcare expenditure, and the need for efficient healthcare delivery models further drive the adoption of POC diagnostics. Market players are also focusing on expanding their product portfolios, enhancing assay performance, and integrating connectivity features to enable seamless data management and remote monitoring. Furthermore, strategic collaborations between diagnostic companies and healthcare providers aim to streamline POC testing workflows and improve patient outcomes.

Point of Care Diagnostics Market Trend: Rapid Adoption of Point-of-Care Testing for Infectious Diseases

A prominent trend in the point-of-care diagnostics market is the rapid adoption of point-of-care testing (POCT) for infectious diseases. With the increasing global burden of infectious diseases such as COVID-19, there is a growing need for rapid and accurate diagnostic solutions that can be performed at the point of care, outside traditional laboratory settings. POCT devices offer advantages such as rapid turnaround times, decentralized testing capabilities, and ease of use, making them indispensable tools for disease detection and management in diverse healthcare settings. The trend towards POCT for infectious diseases reflects a shift towards proactive and timely healthcare interventions to improve patient outcomes and public health outcomes.

Point of Care Diagnostics Market Driver: Demand for Immediate Results and Timely Interventions

A significant driver in the point-of-care diagnostics market is the demand for immediate results and timely interventions in patient care. Healthcare providers increasingly rely on POCT devices to obtain rapid diagnostic information at the point of care, enabling prompt treatment decisions and interventions. The need for quick turnaround times, especially in emergency situations or resource-limited settings, drives the adoption of POCT devices across various healthcare settings, including hospitals, clinics, ambulatory care centers, and community health centers. The emphasis on timely diagnosis and treatment drives market growth as healthcare systems prioritize strategies to improve patient outcomes and streamline healthcare delivery.

Point of Care Diagnostics Opportunity: Expansion into Remote Monitoring and Chronic Disease Management

An exciting potential opportunity in the point-of-care diagnostics market lies in the expansion into remote monitoring and chronic disease management. As healthcare systems shift towards value-based care models and population health management approaches, there is a growing emphasis on proactive disease prevention, early detection, and remote monitoring of chronic conditions. POCT devices offer the potential to facilitate remote monitoring of biomarkers, disease progression, and treatment response, enabling personalized and proactive healthcare interventions. By expanding into remote monitoring solutions and chronic disease management programs, companies can leverage POCT technologies to address unmet needs in disease management, improve patient outcomes, and capture new market opportunities in the evolving landscape of healthcare delivery.

Point of Care Diagnostics Market Segmentation

By Product

Glucose Testing
Hb1Ac Testing
Coagulation Testing
Fertility/Pregnancy
Infectious Disease
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug of Abuser (DOA) Testing
Autoimmune Diseases
Urinalysis/Nephrology

By End user

Clinics
Hospitals
Home
Assisted Living Healthcare Facilities
Laboratory

Geographical Analysis

North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Point of Care Diagnostics Market Companies

Abbott
AccuBioTech Co., Ltd
ALPHA LABORATORIES
Anbio Biotechnology Co., Ltd.
Becton Dickinson (BD)
bioMérieux
Danaher Corporation
EKF Diagnostics Holdings plc.
F. Hoffmann-La Roche Ltd.
Nova Biomedical
Orasure Technologies, Inc.
Qiagen
QuidelOrtho Corporation
Sekisui Diagnostics
Siemens Healthcare GmbH
Spectral Medical, Inc.
Trinity Biotech
Trividia Health, Inc.
Werfen

Reasons to Buy the Point of Care Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Point of Care Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Point of Care Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Point of Care Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Point of Care Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Point of Care Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Point of Care Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Point of Care Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Point of Care Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Point of Care Diagnostics Market Industry
4.2 Key Market Trends in Point of Care Diagnostics Market Industry
4.3 Potential Opportunities in Point of Care Diagnostics Market Industry
4.4 Key Challenges in Point of Care Diagnostics Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Point of Care Diagnostics Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Point of Care Diagnostics Market Outlook By Segments
7.1 Point of Care Diagnostics Market Outlook by Segments
By Product
Glucose Testing
Hb1Ac Testing
Coagulation Testing
Fertility/Pregnancy
Infectious Disease
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug of Abuser (DOA) Testing
Autoimmune Diseases
Urinalysis/Nephrology